title: Commentary on H. Ide et al., "Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells".
authors: Department of Pharmacology, Medical University of Vienna, Waehringerstrasse 13A, A-1090 Vienna, Austria.
authors: Christian
authors: C
authors: Schuster
authors: Mathias
authors: M
authors: Müller
authors: Michael
authors: M
authors: Freissmuth
authors: Veronika
authors: V
authors: Sexl
authors: Dagmar
authors: D
authors: Stoiber
mesh_terms: D000818:Animals; D002051:Burkitt Lymphoma / Q000201:enzymology; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008297:Male; D051379:Mice; D009361:Neoplasm Invasiveness; D011471:Prostatic Neoplasms / Q000201:enzymology* / Q000473:pathology*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D053634:TYK2 Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D047428:Protein Kinase Inhibitors; D053634:TYK2 Kinase